TipRanks
2 ‘Strong Buy’ Biotech Stocks That Can Inject a Healthy Dose of Upside
For investors seeking strong returns, few market sectors can offer the high potential found in biotech. It doesn’t come easy, though. Biotech firms are notorious for running losses. The lead-times for new product development are frequently measured in years, and overhead costs in the millions – and those costs are front-loaded. A large portion of these companies are involved in cutting edge research – on new drugs, new device technology, and new treatments. Hitting on an effective novel treatmen
